Improving Cognitive Aptitudes With tDCS in Patients With Multiple Scle
Improving Cognitive Aptitudes With tDCS in Patients With Multiple Sclerosis / Améliorer Les capacités Cognitives Par tDCS Chez Les Patients Souffrants de sclérose en Plaques
What it found
The trial ended early for another reason (see below).
Reason given: lack of recruitement
This trial finished 3 years ago. We found no results in the registry or in any paper that cites it.
What was tested
Treatment tested
- tDCS
What it measured
Main measures
Enhancement of Cognitive aptitudes with tDCS
from baseline to 4 weeks after the intervention
Thinking and memory
Other measures (2)
Enhancement of Motor skills with tDCS
from baseline to 4 weeks after the intervention
Impact on Fatigue and Enhancement of Cognitive performances with tDCS
from baseline to 4 weeks after the intervention
Thinking and memoryFatigue
Who could take part
Relapsing and progressive · 18 to 65
Show the full criteria
Inclusion criteria
* MS patients with relapsing remitting MS/secondary progression MS (based on the 2010 revised McDonald criteria) * Cognitive deficits * Motor deficits
Exclusion criteria
* contraindication to tDCS (seizure or epilepsy, metal in the head, …) * major psychiatric conditions or major depression * coexisting instable medical condition * substance or alcohol abuse * regular intake of drug that strongly modulate brain excitability * major sequels from MS preventing participation in the study * pregnancy
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
Noninvasive brain stimulations (NIBS) will be used in MS patients with cognitive impairments to enhance their cognitive aptitudes.
Loading reviews and guidelines…
History
Started
Oct 2014
Main results due
May 2023
Finished
May 2023